sixty-nine percent of patients continued treatment with amiodarone and had no recurrence of symptomatic vt or ventricular fibrillation ( vf ) over a follow-up of 6 to 52 months ( mean +/- standard deviation 14.2 +/- 8.2 ) .
C0002598
amiodarone
C0042510
ventricular fibrillation